PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378608
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378608
Plant-based Vaccines Market, By Vaccine Type, By Source, By Application, By Geography
The global plant-based vaccines market is estimated to be valued at US$ 95.9 million in 2023 and is expected to exhibit a CAGR of 51.3% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 95.9 Mn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 51.30% | 2030 Value Projection: | US$ 1,739.1 Mn |
Vaccines are the most cost-effective and efficacious means of reducing the disease burden of infectious diseases. Novel approaches to improve product quality and improve access while lowering production costs are continuously sought. Traditionally, vaccines are prepared by using an attenuated version of the pathogen or by preparing and inactivating a disease-causing organism or a suitable part of it, e.g. a toxin, and administering it in quantities sufficient to induce immunity. Such vaccines have the unavoidable potential for contamination with adventitious agents that can infect such materials. A new and exciting possibility is the production of vaccine antigens in genetically modified plants, which can then be extracted and purified by conventional methods. Such vaccines could either be eaten or applied to mucosal surfaces. Plant-derived vaccines have several advantages. They are easily tolerated by patients, can be made cheaply in very large quantities, and the antigens obtained from them are stable and can be kept in storage for a very long time. The likelihood that contamination by a plant virus would have an adverse effect on humans is almost negligible. There are several technical challenges concerning plant-derived vaccines that must be resolved before they can enter wide-scale use, and the regulatory requirements for this novel class of vaccines must be established. In addition, public acceptance of the new technology must be ensured.
Market Dynamics
Increasing product launches by key players in the market are expected to drive the growth of the global plant-based vaccines market over the forecast period. For instance, in December 2022, Evonik, a chemical company, announced the launch of plant-based squalene to boost vaccine efficacy. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene.
Key features of the study:
- This report provides an in-depth analysis of the global plant-based vaccines market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global plant-based vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI).
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global plant-based vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plant-based vaccines market
Global Plant-based Vaccines Market Detailed Segmentation:
- By Vaccine Type:
- Bacterial Vaccines
- Viral Vaccines
- Parasite Vaccines
- Others
- By Source:
- Tobacco Plant
- Maize
- Potato
- Others
- By Application:
- Influenza
- COVID-19
- Zika Virus
- Ebola Virus
- Poultry Disease
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Medicago, Inc.
- IBIO, Inc.
- Icon Genetics GmbH
- Lumen Bioscience, Inc.
- British American Tobacco Plc.
- Creative Biolabs, Inc.
- Leaf Expression Systems Ltd.
- ZYUS Life Sciences Inc.
- PlantForm Corporation
- Infectious Disease Research Institute (IDRI)
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Plant-based Vaccines Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Plant-based Vaccines Market, By Vaccine Type, 2018-2030, (US$ Mn )
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn )
- Segment Trends
- Viral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
- Parasite Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
6. Global Plant-based Vaccines Market, By Source, 2018-2030, (US$ Mn )
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Tobacco Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
- Maize
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
- Potato
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
7. Global Plant-based Vaccines Market, By Application, 2018-2030, (US$ Mn )
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Covid-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Ebola Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Poultry Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
8. Global Plant-based Vaccines Market, By Region, 2018-2030, (US$ Mn )
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018 - 2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn )
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Medicago, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- IBIO, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Icon Genetics GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Lumen Bioscience, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- British American Tobacco Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Creative Biolabs, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Leaf Expression Systems Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- ZYUS Life Sciences Inc.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- PlantForm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Infectious Disease Research Institute (IDRI)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
